Welcome to our dedicated page for AVAX ONE TECHNOLOGY LTD. SEC filings (Ticker: AVX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Avax One Technology Ltd. filings document a British Columbia public company operating across digital assets, Bitcoin mining, and AI/HPC infrastructure. Its Form 8-K reports include press releases, investor presentation materials, prospectus supplement-related legality opinions, selling stockholder disclosures, and Nasdaq listing-compliance matters.
The company’s proxy materials cover annual meeting governance matters, including director elections, board size, and auditor ratification. Registration-related filings and exhibits describe common-share resale arrangements, capital-structure disclosures, forward-looking statement language, and material updates tied to its Avalanche treasury strategy and powered-land infrastructure plans.
AVAX One Technology Ltd. filed a current report to note that it has submitted a prospectus supplement under its effective shelf registration statement on Form S-3. The company is using this report to file the related legality opinion as Exhibit 5.1, a legal confirmation regarding the validity of the securities covered by the prospectus supplement. The filing also reiterates that some statements may be forward-looking and refers readers to the company’s SEC filings for a discussion of risks.
AVAX One Technology Ltd. has filed a prospectus supplement covering the resale of up to 73,849,958 common shares by existing investors. This includes 68,578,175 shares issued in a November 5, 2025 private placement and up to 5,271,783 shares issuable upon conversion of notes and exercise of warrants from an October 24, 2025 tranche of $7,700,000 in convertible debt with a 10% original issue discount for gross proceeds of $6,930,000. The notes and warrants carry a strike and exercise price of $2.41 per share. AVAX is not selling any shares in this offering and will receive no proceeds from shareholder resales, though it may receive cash if warrants are exercised. As context, common shares outstanding were 92,672,203 as of January 21, 2026. The shares may be sold from time to time through various methods at market or negotiated prices, potentially adding selling pressure as investors from the recent financing gain registered liquidity.